Hurricane Capital Advisors’s DiaMedica Therapeutics DMAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$923K Buy
111,582
+44,110
+65% +$308K 0.08% 164
2026
Q2
$475K Hold
67,472
– – 0.12% 177
2026
Q1
$457K Buy
+67,472
New +$535K 0.14% 123

Other funds holding DMAC

Hurricane Capital Advisors's DMAC Position: Q3 2026 in Review

Hurricane Capital Advisors increased its DiaMedica Therapeutics (DMAC) stake by 65% in Q3 2026, buying an estimated $308K and bringing the position to 111,582 shares worth $923K. The position accounts for 0.08% of the portfolio, ranked #164.

Hurricane Capital Advisors first reported a position in DMAC in Q1 2026 and has held it in 3 quarters since. 96 funds tracked by Wall St. Rank hold DMAC as of Q3 2026.

  • Hurricane Capital Advisors held 111,582 shares of DiaMedica Therapeutics worth $923K as of Q3 2026.
  • Hurricane Capital Advisors bought 44,110 DiaMedica Therapeutics shares in Q3 2026, an estimated $308K.
  • DiaMedica Therapeutics made up 0.08% of Hurricane Capital Advisors's portfolio in Q3 2026, its #164 holding.
  • Hurricane Capital Advisors first reported a position in DiaMedica Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 96 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q3 2026.

Based on Hurricane Capital Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.